Topic: ‘ Regulatory Hurdles Regarding the Use of AI in Pharmaceutical Production Setting
We look forward to a thought-provoking exchange of perspectives from industry leaders, technology experts, and regulatory professionals. Join us for an insightful session addressing both the challenges and opportunities AI brings to the pharmaceutical industry.
Panel Members:
Noor Al-Rifai
Scientific Sr. Principal Engineer at Johnson & Johnson
Jonathan Bral
Sector Lead for Digital Transformation in Pharma at Axians Belgium
Matthias Feys
CTO & Co-founder at ML6
Barbara Stubbe
GMDP Inspecteur-Expert at FAGG &
Expert Quality Innovation Group (QIG) at EMA
Host:
Tineke Van Hooland
Founder and CEO at Epic 10